Turn Therapeutics Inc. (TTRX) Stock Profile — Insider Trades & Financials

EPS$-0.13

Market Cap$104.3M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Bradley Burnam

CEO & Executive Director

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Founded: 2015
Employees: 2
Headquarters: Westlake Village, California, United States

⚡

Core Efficiency

D/E Ratio?

1.59

📊

Profitability Ratios

Current Ratio?

0.87

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Aug 29, 2026 (in 142 days)

Annual Report (10-K) — Estimated

Aug 29, 2026

Predicted10-K

Mar 31, 2026

10-KQ4 20251d after period end

Nov 13, 2025

10-QQ3 20251d after period end

Data Freshness

Financial Data

4 days ago

Latest filing: 2026-03-31

SEC Metadata

17 days ago

Latest filing: 2025-11-13